United Kingdom Multicentre Acamprosate Study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol

Alcohol and Alcoholism

Volumn 35, Issue 2, 2000, Pages 176-187

  Chick, J ^a   Howlett, H ^b   Morgan, M Y ^c   Ritson, B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Harrier House   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DIARRHEA; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TABLET; UNEMPLOYMENT; UNITED KINGDOM; VOMITING;

EID: 0034116102     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/35.2.176     Document Type: Article

References (43)

1. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association, Washington, DC.
2. Besson, J., Aeby, F., Kasas, A., Lehert, P. and Potgieter, A. (1998) Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcoholism: Clinical and Experimental Research 22, 573-579.
3. Boismare, F., Daoust, M., Moore, N., Saligaut, C., Lhuintre, J. P., Chretien, P. and Durlach, J. (1984) A homotaurinate derivative reduces the voluntary ethanol intake by rats: are cerebral GABA receptors involved? Pharmacology, Biochemistry and Behavior 21, 787-789.
4. Chick, J. (1997) Evidence of increasing health damage in Scotland related to alcohol. Health Bulletin 53, 134-139.
5. Chick, J., Kreitman, N. and Plant, M. (1981) Mean cell volume and gamma glutamyl transpeptidase as markers of drinking in working men. Lancet i, 1249-1251.
6. Chick, J., Erickson, C. K. and the Amsterdam Consensus Conference Participants (1996) Conference Summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in its Treatment. Alcoholism: Clinical and Experimental Research 20, 391-402.
7. Daoust, M., Legrand, E., Dewiss, M., Heidbreder, C., De Witte, Ph., Tran, G. and Durbin, P. (1992) Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats. Pharmacology, Biochemistry and Behavior 41, 669-674.
8. Ewing, J. A. (1984) Detecting alcoholism: the CAGE questionnaire. Journal of the American Medical Association 252, 1905-1907.
9. Geerlings, P. J., Ansoms, C. and van den Brink, W. (1997) Acamprosate and prevention of relapse in alcoholics European Addiction Research 3, 129-137.
10. Gewiss, M., Heidbreder, C. H., Opsomer, L., Durbin, P. H. and De Witte, Ph. (1991) Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol and Alcoholism 26, 129-137.
11. Grant, K. A. and Woolverton, W. L. (1989) Reinforcing and discriminative effects of acetylhomotaurine in animals. Pharmacology, Biochemistry and Behavior 32, 607-611.
12. Hamilton, M. (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 50-55.
13. Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278-296.
14. Jellinek, E. M. (1960) The Disease Concept of Alcoholism. Hillhouse, New Haven.
15. Ladewig, D., Knecht, Th., Lehert, Ph. and Fend, A. (1993) Acamprosat - ein stabilisierungsfaktor in der langzeitentwohnung von alkoholabhangigen. Therapeutische Umschau 50, 182-187.
16. Lamblin, F., Deuceuninck, D. and De Witte, Ph. (1993) Modulation of alcohol preference by NMDA antagonists in male rate. Alcohol and Alcoholism 28, 639-647.
17. Le Magnen, J., Tran, G. and Durlach, J. (1987a) Lack of effects of Caacetyl homotaurinate on chronic and acute toxicities of ethanol in rats. Alcohol 4, 103-108.
18. Le Magnen, J., Tran, G., Durlach, J. and Martin, C. (19870) Dosedependent suppression of the high alcohol intake of chronically intoxicated rats by calcium acetyl homotaurinate. Alcohol 4, 97-102.
19. Lesch, O. M. and Walter, H. (1996) Subtypes of alcoholism and their role in therapy Alcohol and Alcoholism 31 (Suppl. 1), 59-62.
20. Lhuintre, J. P., Moore, N. D., Saligaut, C. et al. (1985) Ability of calcium bis acetyl homotaurinate, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet i, 1015-1016.
21. Lhuintre, J. P., Moore, N., Tran, G. et al. (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol and Alcoholism 25, 613-622.
22. Littleton, J. (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90, 1179-1188.
23. Miller, W. R., Brown, J. M., Simpson, T. L., Handmaker, N. S., Bien, T. H., Luckie, L. F., Montgomery, H. A., Hester, R. K. and Tonigan, J. S. (1995) What works? A methodological analysis of the alcoholism treatment outcome literature. In Handbook of Alcoholism Treatment Approaches: Effective Alternatives, 2nd edn, Hester, R. K. and Miller, W. R. eds, pp. 12-44. Allyn and Bacon, Boston.
24. Moncrieff, J. and Drummond, C. D. (1998) The quality of alcohol treatment research: an examination of influential controlled trials and development of a quality rating system. Addiction 93, 811-823.
25. Morris, J. B. and Beck, A. T. (1974) The efficacy of antidepressant drugs. Archives of General Psychiatry 30, 667-672.
26. Paille, F. M., Guelfi, J. D., Perkins, A. C., Royer, R. J., Steru, L. and Parot, P. (1995) Randomised multicentre trial of acamprosate in a maintenance programme of abstinence after alcohol detoxification. Alcohol and Alcoholism 30, 239-247.
27. Patience, D., Buxton, M., Chick, J., Howlett, H., McKenna, M. and Ritson, B. (1997) The SECCAT Survey (II): The alcohol related problems questionnaire as a proxy for resource costs and quality of life in alcoholism treatment. Alcohol and Alcoholism 32, 79-84.
28. Pelc, I., Le Bon, O., Verbanck, P., Lehert, P. H. and Opsomer, L. (1992) Calcium acetyl homotaurinate for maintaining abstinence in weaned alcoholic patients; a placebo controlled double-blind multi-centre study. In Novel Pharmacological Interventions for Alcoholism, Naranjo, C. and Sellers, E. M. eds, pp. 348-352. Springer-Verlag, New York.
29. Pelc, I., Verbanck, P., Le Bon, M., Gavrilovic, M., Lion, K. and Lehert P. (1997) Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients: a 90-day dose finding study British Journal of Psychiatry 171, 73-77.
30. Plinius Maior Society (1994) Guidelines on the Evaluation of Treatment for Alcohol Dependence. Alcoholism - Journal of Alcoholism and Related Disorders 33 (Suppl. 1), 3-83.
31. Poldrugo, F. (1997) Acamprosate treatment in a long-term community based alcohol rehabilitation programme. Addiction 92, 1537-1547.
32. Project MATCH Research Group (1997) Matching alcoholism treatment to client heterogeneity: Project MATCH post-treatment drinking outcomes. Journal of Studies on Alcohol 58, 7-29.
33. Rassnick, S., D'Amico, E., Riley, E., Pulvirenti, L., Ziegelgansberger, W. and Koob, G. F. (1992) GABA and nucleus accumbens glutamate neurotransmision modulate ethanol self-administration in rats. Annals of the New York Academy of Sciences 654, 502-505.
34. Roussaux, J.-P., Hers, D. and Ferauge, M. (1996) L'acamprosate diminue-t'il l'appétence pour l'alcool chez l'alcoolique sevré. Journal de Pharmacie de Belgique 51, 65-68.
35. Sass, H., Soyka, M., Mann, K. and Zieglgansberger, W. (1996) Relapse prevention by acamprosate: results from a placebo controlled study on alcohol dependence. Archives of General Psychiatry 53, 673-680.
36. Selzer, M. L. (1971) The Michigan Alcoholism screening test: the quest for a new diagnostic instrument. American Journal of Psychiatry 127, 1653-1658.
37. Soyka, M. (1996) Clinical efficacy of acamprosate in the treatment of alcoholism. In Acamprosate in Relapse Prevention of Alcoholism: Proceedings of the 1st CAMRAL Symposium, ESBRA, Stuttgart, 1995, Soyka, M. ed., pp. 155-171. Springer, Berlin.
38. Stockwell, T., Murphy, D. and Hodgson, R. (1983) The Severity of Alcohol Dependence Questionnaire: its use, reliability and validity. British Journal of Addiction 78, 145-155.
39. Tempesta, E., Janiri, L., Bignamini, A., Chabac, S. and Potgieter, A. (2000) Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Alcohol and Alcoholism 35, 202-209.
40. Tsai, G., Gastfriend, D. R. and Coyle, J. T. (1995) The glutamatergic basis of alcoholism. American Journal of Psychiatry 152, 332-340.
41. Tsai, G., Ragan, P., Chang, R., Chen, S., Linnoila, M. I. and Coyle, J. T. (1998) Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. American Journal of Psychiatry 155, 726-732.
42. Whitworth, A. B., Fischer, F., Lesch, O., Nimmerrichter, A., Oberauer, H., Platz, T., Potgieter, A., Walter, H. and Fleischhacker, W. W. (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347, 1438-1442.
43. Zeise, M. L., Kasparov, S., Capogna, M. and Zieglgansberger, W. (1993) Acamprosate (calcium-acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. European Journal of Pharmacology 231, 47-45.